Date: This activity was pre-recorded on December 2, 2020 from 1:00pm – 2:00pm ET. Participants must review in its entirety, pass the post-test with a score of 70% or higher and evaluate the course to receive full credit.
Cost: Free for Members, $15 Non-Members
*If you are looking for BCGP version, please click here
*This activity is NOT FL Consultant Approved
Speaker:
Marketa Marvanova, PharmD, PhD, BCGP, BCPP, FASCP
Dean and Professor
Skaggs School of Pharmacy, University of Montana
Financial Disclosure:
Dr. Marvanova serves as a clinical pharmacy specialist consultant in neurology and psychiatry for Lexicomp, Wolters Kluwer. Dr. Marvanova will discuss off-label use clozapine, and amantadine.
Target Audience:
This activity will provide an overview on management strategies of motor fluctuations with emphasis on novel therapies including new medication classes, and improved drug delivery of dopaminergic therapy including wearable devices. It is crucial that geriatric pharmacists are knowledgeable about strategies to promote optimal quality of life for those suffering from PD to provide high-quality PD care, counselling and education.
Learning Objectives:
At the conclusion of this application-based activity, participants should be able to:
- Discuss common motor complications in Parkinson disease.
- Describe the strategies for management of motor fluctuations in Parkinson disease and understand their place in therapy.
- Describe the clinical pharmacology and efficacy of newly approved medications and devices for management of motor complications in Parkinson disease.
- Based on a clinical scenario, recommend appropriate treatment plan for motor complications in Parkinson disease.
Continuing Pharmacy Education:
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
UAN: 0203-0000-21-001-H01-P
Credits: 1.5 CPE hours (1 hour of recorded content, 0.5 hours for post-test assessment)
Expiration: January 1, 2024 by 11:59pm ET
*This home study version was released on January 5th, 2021. Each user has 365 days of access post-purchase OR its expiration date January 1st, 2024, whichever occurs first.
How to Earn Credit:
Post-Test: You will have unlimited attempts to achieve a 70% or higher on the post-test assessment.
CPE Credit: You must complete the post-test and evaluation within 365 days post purchase or by its expiration date: January 7, 2024, whichever occurs first to receive credit. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website.
Computer hardware/software Technical assistance help